Skip to content
SPACListing
CompletedNasdaq

SkinHealth Systems Inc.SKIN

Class A SKINCIK 0001818093

Cash in trust

—

Not yet disclosed

Trust per share

—

Redemption value

IPO

Oct 2020

—

Combination deadline

—

Not disclosed

Filings on record

438

Latest Oct 14, 2026

Business combination

Target
Not disclosed in an indexed filing
Announced
Jan 1, 2021
Closed
May 11, 2021

Overview

SkinHealth Systems Inc. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001818093. It completed its initial public offering in Oct 2020 and listing on Nasdaq. Class A shares trade under the ticker SKIN on Nasdaq. Business combination closed; the company trades under a new ticker.

How busy it has been

Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.

281402020-082026-10

438 filings in all. 12 in the last three months, against a busiest month of 28.

News on SkinHealth Systems Inc.

Last 90 days

News sentiment

Neutral
negativeneutralpositive

Across 4 recent stories, weighted towards the newest. Scored by our own headline classifier using finance- and SPAC-specific terms. It reads what a story is about, not what the shares are worth.

SEC filing history

Free tier: filings older than 24 hours
  • 8-K

    Regulation FD disclosure

    Items 3.03, 5.03, 7.01, 9.01 · Accession 0001628280-26-065833

    Oct 14, 2026

    1d ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001628280-26-065692

    Oct 14, 2026

    1d ago

    View on EDGAR ↗
  • 8-K

    Termination of a material definitive agreement; Regulation FD disclosure

    Items 1.02, 7.01 · Accession 0001628280-26-065232

    Oct 7, 2026

    8d ago

    View on EDGAR ↗
  • 8-K

    Submission of matters to a vote of security holders

    Item 5.07 · Accession 0001628280-26-063712

    Sep 29, 2026

    16d ago

    View on EDGAR ↗
  • 8-K

    Current report

    Item 5.02 · Accession 0001628280-26-061326

    Sep 11, 2026

    1mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Item 5.02 · Accession 0001628280-26-057096

    Aug 15, 2026

    2mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001628280-26-056277

    Aug 13, 2026

    2mo ago

    View on EDGAR ↗
  • DEFA14A

    Additional proxy soliciting material

    Accession 0001683168-26-006276

    Aug 13, 2026

    2mo ago

    View on EDGAR ↗
  • DEF 14A

    Definitive proxy statement

    Accession 0001683168-26-006273

    Aug 13, 2026

    2mo ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001628280-26-054476

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Items 2.02, 9.01 · Accession 0001628280-26-054309

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • PRE 14A

    PRELIMINARY PROXY STATEMENT

    Accession 0001683168-26-005869

    Aug 1, 2026

    2mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0002012383-26-002253

    Jul 28, 2026

    2mo ago

    View on EDGAR ↗
  • SCHEDULE 13G

    Beneficial ownership report (passive)

    Accession 0002052113-26-000738

    Jul 17, 2026

    3mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001901361-26-000011

    Jul 13, 2026

    3mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0000315066-26-001466

    Jul 8, 2026

    3mo ago

    View on EDGAR ↗
  • 8-K

    Other events

    Item 8.01 · Accession 0001628280-26-044620

    Jun 23, 2026

    3mo ago

    View on EDGAR ↗
  • 8-K

    Submission of matters to a vote of security holders

    Item 5.07 · Accession 0001628280-26-043539

    Jun 17, 2026

    4mo ago

    View on EDGAR ↗
  • 8-K/A

    8-K/A

    Items 5.02, 9.01 · Accession 0001628280-26-037340

    May 22, 2026

    4mo ago

    View on EDGAR ↗
  • 144

    144 filing

    Accession 0001959173-26-003840

    May 21, 2026

    4mo ago

    View on EDGAR ↗
  • 8-K

    Notice of delisting or failure to satisfy a listing rule

    Item 3.01 · Accession 0001628280-26-034101

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • SCHEDULE 13D/A

    SCHEDULE 13D/A filing

    Accession 0001193125-26-217467

    May 12, 2026

    5mo ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001628280-26-032326

    May 8, 2026

    5mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Items 2.02, 9.01 · Accession 0001628280-26-032099

    May 8, 2026

    5mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Item 5.02 · Accession 0001628280-26-031243

    May 7, 2026

    5mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0000315066-26-001102

    May 6, 2026

    5mo ago

    View on EDGAR ↗
  • ARS

    ANNUAL REPORT

    Accession 0001683168-26-003190

    Apr 25, 2026

    5mo ago

    View on EDGAR ↗
  • DEF 14A

    Definitive proxy statement

    Accession 0001683168-26-003189

    Apr 25, 2026

    5mo ago

    View on EDGAR ↗
  • 3

    Initial statement of beneficial ownership

    Accession 0001628280-26-026560

    Apr 23, 2026

    5mo ago

    View on EDGAR ↗
  • 3

    Initial statement of beneficial ownership

    Accession 0001628280-26-026559

    Apr 23, 2026

    5mo ago

    View on EDGAR ↗

Pro

Track SKIN without the delay

Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.

  • Filings live, no 24-hour delay
  • One click through to the source document
  • Deadline calendar out to 12 months
  • CSV export, API and MCP access

Cancel any time. Billed monthly in USD.

SkinHealth Systems Inc.: questions answered

What is SkinHealth Systems Inc. (SKIN)?

SkinHealth Systems Inc. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001818093. It completed its initial public offering in Oct 2020 and listing on Nasdaq. Class A shares trade under the ticker SKIN on Nasdaq. Business combination closed; the company trades under a new ticker.

How much does SkinHealth Systems Inc. hold in trust?

No trust balance has been disclosed in a filing we have indexed for SkinHealth Systems Inc.. For a newly priced IPO this is normal: the figure first appears in the quarterly report after closing.

When must SkinHealth Systems Inc. complete a merger?

No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.

What happens if SkinHealth Systems Inc. does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in SkinHealth Systems Inc., and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

What tickers does SkinHealth Systems Inc. trade under?

Class A shares trade as SKIN on Nasdaq. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.

Is the trust value the same as the share price for SkinHealth Systems Inc.?

No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.

Is SkinHealth Systems Inc. tradeable, and where?

Yes. SKIN returned a live quote of $12.60 on Nasdaq. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.

Is SkinHealth Systems Inc. a good investment?

That is not a question this site answers. SkinHealth Systems Inc. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this SkinHealth Systems Inc. data come from?

Filings SkinHealth Systems Inc. submitted to the SEC under CIK 0001818093: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Oct 15, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.